₹821.80 3.60 (0.44%)
10:22 AM, 30-Sep-2026₹819.85 1.15 (0.14%)
10:09 AM, 30-Sep-2026BSE : 544222
NSE : AKUMS
Sector : Health care
ISIN Code : INE09XN01023
Last Updated: 30-Sep-2026 | 03:52 PM IST
| Market Cap (₹ Cr.) | 12,935 |
Traded Value (₹ Cr) | 0.16 |
Volume (Shares) | 1,967 |
Face Value (₹) | 2 |
52-Week High (₹) | 839.25 |
52-Week High Date | 23-Sep-2026 |
52-Week Low (₹) | 410.10 |
52-Week Low Date | 21-Jan-2026 |
All Time High (₹) | 1,174.85 |
All Time High Date | 20-Aug-2024 |
All Time Low (₹) | 407.40 |
All Time Low Date | 07-Apr-2025 |
| PARAMETER | VALUES |
|---|---|
| Market Cap (₹ Cr.) | 12,904 |
| EPS - TTM (₹) [C] | 18.60 |
| P/E Ratio (X) [C] | 44.08 |
| Face Value (₹) | 2 |
| Latest Dividend (%) | 50.00 |
| Latest Dividend Date | 03-Jul-2026 |
| Dividend Yield (%) | 0.36 |
| Book Value Share (₹) [C] | 210.57 |
| P/B Ratio (₹) [C] | 3.89 |
| Scheme Name | Amount Invested (₹ Cr) | No Of Shares | Net Asset (%) |
|---|---|---|---|
| Franklin India Opportunities Fund - (G) | 196.77 | 25,33,367 | 2.02 |
| Franklin India Opportunities Fund - (IDCW) | 196.77 | 25,33,367 | 2.02 |
| Franklin India Opportunities Fund - Direct (IDCW) | 196.77 | 25,33,367 | 2.02 |
| Franklin India Opportunities Fund - Direct (G) | 196.77 | 25,33,367 | 2.02 |
| Franklin India Small Cap Fund - Direct (IDCW) | 164.45 | 21,17,232 | 1.12 |
| Franklin India Small Cap Fund (G) | 164.45 | 21,17,232 | 1.12 |
| Franklin India Small Cap Fund (IDCW) | 164.45 | 21,17,232 | 1.12 |
| Franklin India Small Cap Fund - Direct (G) | 164.45 | 21,17,232 | 1.12 |
| ICICI Pru Healthcare Fund (IDCW) | 139.48 | 17,95,770 | 1.99 |
| ICICI Pru Healthcare Fund (G) | 139.48 | 17,95,770 | 1.99 |
Load more
| Today's Low/High (₹) | 817.05 828.20 |
| Week Low/High (₹) | 798.00 839.00 |
| Month Low/High (₹) | 733.15 839.00 |
| Year Low/High (₹) | 409.30 839.00 |
| All time Low/High (₹) | 407.40 1,176.00 |
| Period | BSE | NSE | SENSEX | NIFTY |
|---|---|---|---|---|
| 1 Week | -0.47% | -0.42% | -2.60% | -3.02% |
| 1 Month | 6.13% | 6.12% | -5.67% | -5.94% |
| 3 Month | 31.58% | 31.57% | -4.70% | -4.72% |
| 6 Month | 75.91% | 75.90% | 1.30% | 1.83% |
| 1 Year | 84.98% | 85.72% | -9.20% | -7.61% |
| 3 Year | - | - | 10.72% | 15.79% |
ED / MD / Promoter : SANJEEV JAIN
ED / MD / Promoter : SANDEEP JAIN
Whole-time Director : Sanjay Sinha
Independent Non Exe. Director : Kewal Handa
Independent Non Exe. Director : Matangi Gowrishankar
Independent Non Exe. Director : SATWINDER SINGH
Non-Exec & Non-Independent Dir : SUNIL KUMAR THAKUR
Independent Non Exe. Director : Anil Kumar Arvindlal Amin
Company Sec. & Compli. Officer : DHARAMVIR MALIK
Registered Office: 304 Mohan Place LSC Saraswati, Vihar,Delhi,Delhi-110034 Ph: +91 11 6904 1000
Email:cs@akums.net
1. What's the Akums Drugs & Pharmaceuticals Ltd share price today?
Akums Drugs & Pharmaceuticals Ltd share price was Rs 821.80 at 10:22 AM IST on 30th Sep 2026. Akums Drugs & Pharmaceuticals Ltd share price was up by 0.44% over the previous closing price of Rs 818.20. Akums Drugs & Pharmaceuticals Ltd share price trend:
2. How can I quickly analyse the performance of the Akums Drugs & Pharmaceuticals Ltd stock?
The performance of the Akums Drugs & Pharmaceuticals Ltd stock can be quickly analysed on the following metrics:
3. What is the market cap of Akums Drugs & Pharmaceuticals Ltd?
Akums Drugs & Pharmaceuticals Ltd has a market capitalisation of Rs 12,935 crore.
4. What is Akums Drugs & Pharmaceuticals Ltd's 52-week high/low share price?
The Akums Drugs & Pharmaceuticals Ltd’s 52-week high share price is Rs 839.25 and 52-week low share price is Rs 410.10.
5. Is the Akums Drugs & Pharmaceuticals Ltd profitable?
On a consolidated basis, Akums Drugs & Pharmaceuticals Ltd reported a profit of Rs 100.98 crore on a total income of Rs 1,197.01 crore for the quarter ended 2026. For the year ended 2026, Akums Drugs & Pharmaceuticals Ltd had posted a profit of Rs 256.40 crore on a total income of Rs 4,359.02 crore.
6. Which are Akums Drugs & Pharmaceuticals Ltd’s peers in the Health care sector?
Akums Drugs & Pharmaceuticals Ltd’s top 5 peers in the Health care sector are Marksans Pharma, Natco Pharma, Concord Biotech, Akums Drugs, Corona Remedies, Viyash Scientific, Strides Pharma.
7. Who owns how much in Akums Drugs & Pharmaceuticals Ltd?
Key changes to the Akums Drugs & Pharmaceuticals Ltd shareholding are as follows: